Raia Drogasil S.A. RADLY
OTC PK
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.39% | 9.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.39% | 9.10% | |||
| Cost of Revenue | 1.61% | 7.00% | |||
| Gross Profit | 0.96% | 13.55% | |||
| SG&A Expenses | 2.16% | 8.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 182.22% | -96.91% | |||
| Total Operating Expenses | 1.86% | 5.38% | |||
| Operating Income | -4.35% | 91.63% | |||
| Income Before Tax | -7.16% | 335.95% | |||
| Income Tax Expenses | -20.23% | 680.83% | |||
| Earnings from Continuing Operations | -3.58% | 194.61% | |||
| Earnings from Discontinued Operations | -100.18% | -26.17% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.46% | 178.38% | |||
| EBIT | -4.35% | 91.63% | |||
| EBITDA | -2.71% | 64.80% | |||
| EPS Basic | -5.49% | 178.69% | |||
| Normalized Basic EPS | -3.90% | 313.98% | |||
| EPS Diluted | -5.18% | 182.02% | |||
| Normalized Diluted EPS | -3.69% | 316.48% | |||
| Average Basic Shares Outstanding | 0.01% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.34% | -1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | 186.88% | |||